000 | 01691 a2200493 4500 | ||
---|---|---|---|
005 | 20250516163837.0 | ||
264 | 0 | _c20140305 | |
008 | 201403s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0070587 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Jing | |
245 | 0 | 0 |
_a9-Phenanthrol, a TRPM4 inhibitor, protects isolated rat hearts from ischemia-reperfusion injury. _h[electronic resource] |
260 |
_bPloS one _c2013 |
||
300 |
_ae70587 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 |
_aDecanoic Acids _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aGlucose |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aHydroxy Acids _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aKATP Channels _xantagonists & inhibitors |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aPhenanthrenes _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aTRPM Cation Channels _xantagonists & inhibitors |
650 | 0 | 4 | _aTromethamine |
700 | 1 | _aTakahashi, Ken | |
700 | 1 | _aPiao, Hulin | |
700 | 1 | _aQu, Peng | |
700 | 1 | _aNaruse, Keiji | |
773 | 0 |
_tPloS one _gvol. 8 _gno. 7 _gp. e70587 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0070587 _zAvailable from publisher's website |
999 |
_c22995565 _d22995565 |